WASHINGTON (dpa-AFX) - Boston Scientific Corporation (BSX) announced the pricing of a public offering of $1.85 billion aggregate principal amount of its senior notes. The public offering consists of $600 million of 2.850% notes due May 15, 2020, $500 million of 3.375% notes due May 15, 2022, and $750 million of 3.850% notes due May 15, 2025.
The company intends to use the net proceeds, together with borrowings under its $750 million five-year term loan facility, to: pay the purchase price of the American Medical Systems urology portfolio and to pay related fees and expenses; redeem all or a portion of its 5.500% notes due November 2015, and 6.400% notes due June 2016, and to pay related fees, expenses and premiums.
Copyright RTT News/dpa-AFX